Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 12/20 | 0.51 |
| ▸ | KDR | P35968 | 9/20 | 0.51 |
| ▸ | RET | P07949 | 6/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.45 |
| ▸ | CLK2 | P49760 | 2/20 | 0.41 |
| ▸ | CLK3 | P49761 | 2/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4039574 | 0.96 | CDK1 (0.54) | CDK1KDRRETERBB2CLK2 | |
| Pyrrolidine SCHEMBL5820833 | 0.91 | CDK1 (0.53) | CDK1KDRRETERBB2CLK2 | |
| Piperidine SCHEMBL5823118 | 0.90 | CDK1 (0.52) | CDK1KDRRETERBB2CLK2 | |
| SCHEMBL4035045 | 0.90 | CDK1 (0.57) | CDK1KDRRETERBB2CLK2 | |
| SCHEMBL4033921 | 0.89 | CDK1 (0.56) | CDK1KDRRETERBB2CLK2 | |
| SCHEMBL13797810 | 0.88 | CDK1 (0.56) | CDK1KDRRETERBB2CLK2 | |
| SCHEMBL19497652 | 0.83 | WNT1 (0.46) | RETCLK2CLK3DYRK1AGRM4 | |
| SCHEMBL4033912 | 0.82 | CDK1 (0.72) | CDK1KDRRETERBB2CLK2 | |
| SCHEMBL12370327 | 0.81 | CLK2 (0.56) | CLK2CLK3DYRK1A | |
| SCHEMBL4035660 | 0.81 | CDK1 (0.53) | CDK1KDRRETERBB2FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006130673-A1 | 3-BENZOIMIDAZOLYL-PYRAZOLOPYRIDINES USEFUL IN TREATING KINASE DISORDERS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-12-07 | — | — | WO | disclosed |